ACOR Historical Earnings image   This ACOR historical earnings page last updated 5/23/2022
ACOR Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/11/20220.02B
Q4 20213/9/20220.04B
Q3 202111/9/20210.03B
Q2 20218/5/20210.03B
Q1 20215/6/20210.03B
Q4 20203/4/20210.04B
Q3 202011/3/20200.05B
Q2 20208/4/20200.03B
Q1 20205/5/20200.03B
Q4 20192/13/20200.05B
Q3 201911/4/20190.05B
Q2 20198/1/20190.05B
Q1 20195/2/20190.04B
Q4 20182/14/201969.15M
Q3 201810/31/2018142.81M
Q2 20188/2/2018153.30M
Q1 20185/2/2018106.17M
Q4 20172/15/2018188.40M
Q3 201710/31/2017141.06M
Q2 20177/27/2017139.44M
Q1 20174/27/2017119.39M
Q4 20162/14/2017140.63M
Q3 201610/27/2016135.61M
Q2 20167/28/2016127.46M
Q1 20164/28/2016115.90M
Q4 20152/11/2016130.90M
Q3 201510/22/2015148.20M
Q2 20157/30/2015113.71M
Q1 20154/30/201599.85M
Q4 20142/12/2015117.87M
Q3 201410/30/2014106.00M
Q2 20147/31/201487.40M
Q1 20145/6/201472.50M
Q4 20132/13/201492.60M
Q3 201310/31/201384.92M
Q2 20138/1/201387.10M
Q1 20135/2/201371.90M
Q4 20122/13/201381.47M
Q3 201210/31/201277.40M
Q2 20127/31/201275.70M
Q1 20125/3/201271.25M
ACOR Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q1 20225/11/2022-1.660
Q4 20213/9/2022-0.670
Q3 202111/9/2021-1.430
Q2 20218/5/2021-1.870
Q1 20215/6/2021-2.460
Q4 20203/4/2021-2.500
Q3 202011/3/2020-1.380
Q2 20208/4/2020-2.100
Q1 20205/5/2020-3.060
Q4 20192/13/2020-0.900
Q3 201911/4/2019-2.760
Q2 20198/1/2019-3.300
Q1 20195/2/2019-3.360
Q4 20182/14/20192.700
Q3 201810/31/20181.020
Q2 20188/2/20188.400
Q1 20185/2/20180.840
Q4 20172/15/20183.660
Q3 201710/31/20172.580
Q2 20177/27/20171.740
Q1 20174/27/2017-0.480
Q4 20162/14/20170.300
Q3 201610/27/2016-0.240
Q2 20167/28/20160.420
Q1 20164/28/20160.420
Q4 20152/11/20161.680
Q3 201510/22/20151.860
Q2 20157/30/20151.860
Q1 20154/30/20150.900
Q4 20142/12/20152.760
Q3 201410/30/20141.680
Q2 20147/31/20142.520
Q1 20145/6/20140.120
Q4 20132/13/20140.900
Q3 201310/31/20132.280
Q2 20138/1/20131.500
Q1 20135/2/20130.540
Q4 20122/13/20131.440
Q3 201210/31/20122.280
Q2 20127/31/20121.620
Q1 20125/3/20121.140
Quotes delayed 20 minutes

Email EnvelopeFree ACOR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Acorda Therapeutics (ACOR) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ACRS Past Earnings
ACRX Past Earnings
ADGI Past Earnings
ADIL Past Earnings
ADMA Past Earnings
ADMP Past Earnings
ADMS Past Earnings
ADPT Past Earnings
ADTX Past Earnings
ADUS Past Earnings
What was the record high ACOR historical earnings result?
In terms of earnings or revenue, what is the best ACOR historical earnings result that Acorda Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ACOR historical earnings result was set in Q2 2018, when Acorda Therapeutics posted results of 8.400/share. The most successful revenue quarter within our data set was Q4 2017 when Acorda Therapeutics reported revenue of 188.40M.

What was the lowest Acorda Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ACOR has reported, and when?

✔️Accepted answer: Within our data set, the lowest ACOR historical earnings result was set in Q1 2019, when Acorda Therapeutics posted results of -3.360/share. The smallest revenue quarter within our data set was Q1 2022 when Acorda Therapeutics reported revenue of 0.02B.

On this page we presented the ACOR historical earnings date information for Acorda Therapeutics. Reviewing that ACOR Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2018, when ACOR posted adjusted EPS of 8.400/share. Meanwhile the lowest ACOR historical earnings result was in Q1 2019, when ACOR posted adjusted EPS of -3.360/share. Moving to Acorda Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2017 when ACOR reported 188.40M in revenue, while the smallest revenue quarter was Q1 2022 when ACOR reported 0.02B in revenue.

For self directed investors doing their due diligence on ACOR or any other given stock, their research can benefit from looking into all of the Acorda Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Acorda Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ACOR. Thanks for visiting, and the next time you need to research ACOR historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: RADA shares outstanding history, Funds Holding CREX, ROAN shares outstanding history.

 

ACOR Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.